Rare diseases
Investigational molecules
Locations
Back to Norway3 clinical trials in Moss, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayNorwayNorwayThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on giant cell arteritis (GCA), exploring innovative therapeutic approaches for this rare inflammatory blood vessel condition. The trials aim to evaluate new treatment combinations that could improve patient outcomes while optimizing glucocorticoid therapy regimens.
These investigations are designed to assess the effectiveness of combining novel biological treatments with traditional steroid therapies, potentially offering new hope for patients managing chronic inflammatory conditions.
Advanced studies evaluating combination therapy approaches that integrate biological agents with standardized glucocorticoid tapering protocols. This research aims to establish more effective treatment strategies while potentially reducing long-term steroid exposure.
The research focuses on developing sustained remission protocols that could revolutionize the standard of care for inflammatory vascular conditions.
Comprehensive evaluation of treatment efficacy and safety in vascular inflammation, with particular attention to sustained disease remission. The research examines both immediate therapeutic responses and long-term outcomes in patients with inflammatory arterial disease.
These trials are designed to provide crucial data on the effectiveness of new therapeutic approaches in achieving and maintaining disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
